CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	As previously reported	Revision of Prior Period, Reclassification, Adjustment [Member]	Issuance of Private Placement shares	Issuance of Registered Direct Offering shares	Common stock	Common stock As previously reported	Common stock Issuance of Private Placement shares	Common stock Issuance of Registered Direct Offering shares	Additional paid in capital	Additional paid in capital As previously reported	Additional paid in capital Issuance of Private Placement shares	Additional paid in capital Issuance of Registered Direct Offering shares	Acc. Other Comprehensive Income (Loss)	Acc. Other Comprehensive Income (Loss) As previously reported	Treasury stock	Treasury stock As previously reported	Accumulated deficit	Accumulated deficit As previously reported	Accumulated deficit Revision of Prior Period, Reclassification, Adjustment [Member]
Beginning balance, common shares (in shares) at Dec. 31, 2021						135,566,227	135,566,227
Beginning balance at Dec. 31, 2021	$ 159,688	$ 122,368	$ 37,320			$ 14	$ 14			$ 253,744	$ 253,744			$ 0	$ 0	$ 0	$ 0	$ (94,070)	$ (131,390)	$ 37,320
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(111,367)	(121,674)																(111,367)
Foreign currency translation adjustments, net of tax	0
Equity-based compensation expense	10,865									10,865
Repurchase of shares as a result of Forward Share Purchase Agreements (in shares)						(9,952,803)
Repurchase of shares as a result of Forward Share Purchase Agreements	(57,350)															(57,350)
Issuance of common shares as consideration for the acquisition of Pangiam/ProModel Corporation (in shares)						649,976
Issuance of common shares as consideration for the acquisition of Pangiam/ProModel Corporation	7,501									7,501
Proceeds from exercise of warrants (in shares)						51
Proceeds from exercise of warrants	1									1
Issuance of shares purchased under ESPP (in shares)						508,062
Issuance of shares purchased under ESPP	417									417
Issuance of shares vested for RSUs (in shares)						250,850
Ending balance, common shares (in shares) at Dec. 31, 2022						127,022,363
Ending balance at Dec. 31, 2022	9,755					$ 14				272,528				0		(57,350)		(205,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,187)	(26,214)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Mar. 31, 2023	(11,385)	(54,039)
Beginning balance, common shares (in shares) at Dec. 31, 2022						127,022,363
Beginning balance at Dec. 31, 2022	9,755					$ 14				272,528				0		(57,350)		(205,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(50,017)	(43,109)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Jun. 30, 2023	(20,854)	(61,573)
Beginning balance, common shares (in shares) at Dec. 31, 2022						127,022,363
Beginning balance at Dec. 31, 2022	9,755					$ 14				272,528				0		(57,350)		(205,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(47,135)	(39,110)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Sep. 30, 2023	(12,687)	(52,289)
Beginning balance, common shares (in shares) at Dec. 31, 2022						127,022,363
Beginning balance at Dec. 31, 2022	9,755					$ 14				272,528				0		(57,350)		(205,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(70,657)	(60,366)																(70,657)
Foreign currency translation adjustments, net of tax	0
Equity-based compensation expense	$ 18,671									18,671
Exercise of options (in shares)	12,102
Issuance of Private Placement shares/Registered Direct Offering shares (in shares)								13,888,889	11,848,341
Issuance of Private Placement shares/Registered Direct Offering shares				$ 7,081	$ 6,765			$ 2	$ 1			$ 7,079	$ 6,764
Issuance of shares for equity-based compensation awards, net (in shares)						3,374,625
Issuance of shares for equity-based compensation awards, net	$ (2,790)									(2,790)
Issuance of shares for exercised convertible notes (in shares)						188
Issuance of shares purchased under ESPP (in shares)						1,153,116
Issuance of shares purchased under ESPP	$ 1,176									1,176
Ending balance, common shares (in shares) at Dec. 31, 2023	157,287,522					157,287,522
Ending balance at Dec. 31, 2023	$ (29,999)	(67,335)				$ 17				303,428				0		(57,350)		(276,094)
Beginning balance at Mar. 31, 2023	(11,385)	(54,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(18,830)	(16,895)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Jun. 30, 2023	(20,854)	(61,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	2,882	3,999
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Sep. 30, 2023	(12,687)	(52,289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,522)	(21,256)
Foreign currency translation adjustments, net of tax	$ 0	0
Ending balance, common shares (in shares) at Dec. 31, 2023	157,287,522					157,287,522
Ending balance at Dec. 31, 2023	$ (29,999)	(67,335)				$ 17				303,428				0		(57,350)		(276,094)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(127,792)	(125,147)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Mar. 31, 2024	$ 143,173	108,482
Beginning balance, common shares (in shares) at Dec. 31, 2023	157,287,522					157,287,522
Beginning balance at Dec. 31, 2023	$ (29,999)	(67,335)				$ 17				303,428				0		(57,350)		(276,094)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(142,231)	(136,884)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Jun. 30, 2024	$ 134,745	102,756
Beginning balance, common shares (in shares) at Dec. 31, 2023	157,287,522					157,287,522
Beginning balance at Dec. 31, 2023	$ (29,999)	(67,335)				$ 17				303,428				0		(57,350)		(276,094)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(157,366)	(149,060)
Foreign currency translation adjustments, net of tax	(8)	(8)
Ending balance at Sep. 30, 2024	$ 127,463	98,433
Beginning balance, common shares (in shares) at Dec. 31, 2023	157,287,522					157,287,522
Beginning balance at Dec. 31, 2023	$ (29,999)	(67,335)				$ 17				303,428				0		(57,350)		(276,094)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(295,547)																	(295,547)
Foreign currency translation adjustments, net of tax	121													121
Equity-based compensation expense	$ 21,127									21,127
Exercise of options (in shares)	292,496					292,496
Exercise of options	$ 421									421
Issuance of common shares as consideration for the acquisition of Pangiam/ProModel Corporation (in shares)						63,982,145
Issuance of common shares as consideration for the acquisition of Pangiam/ProModel Corporation	210,757					$ 6				210,751
Proceeds from exercise of warrants (in shares)						22,775,144
Proceeds from exercise of warrants	90,707					$ 2				90,705
Issuance of shares for equity-based compensation awards, net (in shares)						6,138,947
Issuance of shares for equity-based compensation awards, net	(2,669)									(2,669)
Issuance of shares for exercised convertible notes (in shares)						94
Issuance of shares purchased under ESPP (in shares)						1,078,030
Issuance of shares purchased under ESPP	$ 1,368					$ 1				1,367
Ending balance, common shares (in shares) at Dec. 31, 2024	251,554,378					251,554,378
Ending balance at Dec. 31, 2024	$ (3,714)					$ 26				$ 625,130				$ 121		$ (57,350)		$ (571,641)
Beginning balance at Mar. 31, 2024	143,173	108,482
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(14,439)	(11,737)
Foreign currency translation adjustments, net of tax	0	0
Ending balance at Jun. 30, 2024	$ 134,745	$ 102,756